The American Gastroenterological Association (AGA) recently launched Trust Your Gut, an awareness campaign aimed at shortening the time from the onset of bowel symptoms to discussions with a health care provider. As part of the campaign, AGA released new data that shows nearly 40% of Americans have stopped routine activities in the last year due to uncomfortable bowel symptoms, including ...

GI OnDEMAND, a virtual integrated care platform, recently announced a partnership with Mindset Health, the creator of Nerva, a six-week gut-directed hypnotherapy program. The hypnotherapy program is delivered through a mobile app to help patients with irritable bowel syndrome (IBS) better manage their symptoms. GI OnDEMAND is a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., ...

An international study led by the Complutense University of Madrid (UCM) and the National Centre for Cardiovascular Research (CNIC) has found that Lactobacillusbacteria present in the intestinal microbiota interact with immune system cells to strengthen the intestinal barrier. Conducted on mice and published in Immunity, the study opens a new avenue for the treatment of diseases such as ulcerative colitis or Crohn’s ...

Crohn’s disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel diseases (IBD), which may affect as many as 3 million Americans, cost over $6 billion annually, and cause substantial patient morbidity, missed work and school, and diminished quality of life. Currently, anti-TNF therapy is considered first line treatment for moderate-to-severe IBD. However, up to 80 percent of ...

The two most common types of inflammatory bowel diseases are ulcerous colitis and Crohn’s disease. These are diagnosed by camera inside the gut, and by investigating small samples of the gut (biopsies). The diagnosis is often difficult, and if the wrong diagnosis is made, there may be severe consequences for the patients, because the treatments and medications are different between ...